Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edwards Lifesciences

76.02
+0.73000.97%
Post-market: 76.190.1656+0.22%17:56 EDT
Volume:3.79M
Turnover:287.58M
Market Cap:44.63B
PE:10.83
High:76.10
Open:75.09
Low:74.69
Close:75.29
52wk High:83.00
52wk Low:64.89
Shares:587.10M
Float Shares:581.10M
Volume Ratio:0.97
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.02
EPS(LYR):6.98
ROE:15.53%
ROA:8.42%
PB:4.23
PE(LYR):10.88

Loading ...

Edwards Lifesciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
May 14

Piper Sandler Adjusts Price Target on Edwards Lifesciences to $83 From $80, Maintains Overweight Rating

MT Newswires Live
·
May 13

Edwards Lifesciences Corp. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
May 13

Edwards Lifesciences Corporation Conducted Annual Stockholder Meeting

Reuters
·
May 10

Wayne Markowitz, GM & SVP of Surgical, Reports Disposal of Edwards Lifesciences Common Shares

Reuters
·
May 10

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
May 10

Edwards Lifesciences Gets FDA Approval for TAVR in Asymptomatic Aortic Stenosis

MT Newswires Live
·
May 01

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 26

Canaccord Genuity Adjusts Price Target on Edwards Lifesciences to $75 From $71

MT Newswires Live
·
Apr 26

Edwards Lifesciences Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Apr 25

Edwards Lifesciences Corp. Stock Rises 6.6%, Outperforms Competitors

Dow Jones
·
Apr 25

Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens

Benzinga
·
Apr 25

BUZZ-U.S. STOCKS ON THE MOVE- PepsiCo, Procter & Gamble

Reuters
·
Apr 24

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $89 From $85, Maintains Buy Rating

MT Newswires Live
·
Apr 24

Edwards Lifesciences Raised to Overweight From Neutral by Piper Sandler

Dow Jones
·
Apr 24

BUZZ-Edwards Lifesciences rises after co raises 2025 sales forecast

Reuters
·
Apr 24

Piper Sandler Upgrades Edwards Lifesciences to Overweight From Neutral, Adjusts PT to $80 From $73

MT Newswires Live
·
Apr 24

Edwards Lifesciences raises 2025 sales forecast after robust quarter

Reuters
·
Apr 24

Edwards Lifesciences Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 24

Edwards Lifesciences Q1 Adjusted Earnings, Sales Rise; Provides Q2 Guidance

MT Newswires Live
·
Apr 24